Company: ZCARW
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001213900-25-110391
Chunk: 942

Company: Zoomcar Holdings, Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part II, Item 1
Chunk 942
---
,206,386 shares of Common Stock prior
to giving effect to the Second Reverse Split) including shares of Common Stock issuable upon exercise of outstanding warrants.

We also filed resale registration
statements March 4, 2025, to register for resale a total of 6,682,720 shares of Common Stock (133,654,397 shares of Common Stock prior
to giving effect to the Second Reverse Split) including shares of Common Stock issuable upon exercise of outstanding warrants.

All of the remaining Registrable
Securities in the above mentioned offerings were included in those registration statements. These registration statements are still pending
and a large number of such Registrable Securities continue to be unregistered, but upon effectiveness of that registration statement,
it is likely that many of the securities registered for resale thereunder will be sold.

As of March 31, 2025, the Company
entered into a securities purchase agreement, substantially in the same form as the December 2024 SPA and the January 2025 SPA with certain
additional accredited investors in connection with the third closing of the Offering (the “Third Closing”). The Company did
not receive any cash proceeds in the Third Closing. The securities were issued to the investors either (i) as consideration for waiving
certain rights that such investors may have had in connection with a most favored nations provision included in the transaction documents
for a prior financing of Zoomcar, Inc. or (ii) to settle outstanding amounts owed by the Company to its Placement Agent and the Legal
Counsels (Aegis Settlement and Law Firm Settlement described below). Pursuant to the terms and conditions of the Securities Purchase Agreement,
the Company issued to such investors an aggregate of $15,639,099 of securities consisting of 501,318 shares of common stock of the Company,
par value $0.0001 per share (the Common Stock). The Company along with the Common Stock issued (i) Series A Warrants to purchase up to
an aggregate of 6,706,192 shares of Common Stock at an exercise price of $6.24 per share, which takes into account a “share combination
event” adjustment effective following the issuance of such warrants as a result of the Reverse Split (the “Series A Warrants”)
and (ii) Series B Warrants to purchase initially no shares of Common Stock and then up to a maximum of 2,004,955 shares of Common Stock
subject to certain adjustments, at an initial exercise price of $0.002.